Navigation Links
Free Access to Taxotere Instills New Hope among Early Stage Breast Cancer Patients

National Institute for Health and Clinical Excellence said that 10,000 breast cancer patients who are in their early stage of the disease would be given free access to// Taxotere, a chemotherapy drug.

This drug was initially given to those suffering from late-stage breast cancer. Statistics said that this initiative would save more than 600 lives of patients suffering from breast cancer. The guidance comes nine months after the Scottish equivalent of Nice, the Scottish Medicines Consortium, approved the use of Taxotere for Scottish women in the early stages of the disease.

David Miles, consultant oncologist at London Bridge hospital, said that this drug has the potential to prevent the deaths of hundreds of women with breast cancer. He said that this is an important step taken towards the treatment of early stage breast cancer in the UK. Numerous clinical trials confirm that Taxotere-containing regimens are very effective in the treatment of breast cancer. Hence from November every primary care trust will be obliged to offer the drug to breast cancer patients whose cancer has spread to their lymph nodes.


'"/>




Page: 1

Related medicine news :

1. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
2. Scots Do Not Have Access To Proper Dental Care
3. Children In Scotland Denied Access To Dental Care
4. Speedier Access To Advances In Breast Cancer Sought For Patients
5. Patients Have Right To Access Medical Case Papers: Bombay High Court
6. AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment
7. Easy Access To Healthcare Services Essential For Better Survival Rates
8. People Affected By HIV Positive Urge For Better Treatment Access
9. Singapore To Offer More Patients Access To Chronic Disease Management Programs
10. Lack of Proper Emergency Access during the Run Led To the Death of Four Runners
11. Large Scale Free Access On Usage Of HIV Drugs Could Help In Fighting Its Spread
Post Your Comments:
(Date:11/20/2008)... 10 Precision Therapeutics Inc., a...ponse tests, has secured $43 million,in additiona...ization of,ChemoFx(R). ChemoFx is a diagnostic t...ve chemotherapeutic regimen for cancer patients. ...ed the round and was joined by existing,investors...
(Date:11/20/2008)... 20 Precyse Solutions, the leader ...M) performance through,technology and management ...y,Council of Pennsylvania as "Technology Company ...ld at the Kimmel Center. The Annual Gala honors t...anies and entrepreneurs. More,than 1200 business...
(Date:11/20/2008)... 20 In a historic step ...system for financing long-term services and suppor...(LCAO) and the Consortium for Citizens with Disabi...les for reform. , , Together, the two coal...ng seniors, people with disabilities, and provider...
(Date:11/20/2008)...s against infection that can cause meningitis, pne...Y, Nov. 20 (HealthDay News) -- U.S. health officia...ding them to monitor Hib infections, one of the mo...children. , Though the agency has yet to see an...s prompted by a disruption in the supply of vaccin...
Breaking Medicine News(10 mins):Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Precyse Solutions Honored as 'Technology Company of the Year' 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 2Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 3Health News:National Senior and Disability Advocates Agree on Principles for Financing Long-Term Services and Supports 4Health News:CDC Monitors Shortage of Hib Vaccine 2Health News:CDC Monitors Shortage of Hib Vaccine 3
...e magnets that are sold in the market does not pro...h problems//. Magnet that are advertised over the ...es any theoretical and experimental value. Magnet...letes mainly to relive pain but the researchers pr...
...ugs and its effect till 1980. But now things have ...f information available from varied sources// such...databases. The information that is available in t... general public’s understanding and should be made...
...sium on Stem cell Research and Therapy was conduct...e was organized by LifeCell//, a pioneer in stem c...dical College and Research Institute, one of the r...untry. Dr. Mammen Chandy, a leading hematologist,...
...ff (R) said he had filed a bill (HB 1096) that wou...ering the baby// would endanger the life or health... make performing an abortion a Class C felony, car...on sentence. Woodruff said he introduced the bill...
Other Medicine News:Health News:Does Magnet Therapy Posses Healing Powers? 2Health News:Drug Database Goes On Air 2Health News:Stem Cell Research - Changing Wishes to Possibilities and Possibilities to Reality 2
(Date:11/20/2008)... TROMSO, Norway, November 20 Th...ix Biopharma has announced results of studies on i...d at ICAAC in Washington, DC,the studies showed ...apid,bacteriocidal effect, significantly better t...occus pyogenes than marketed gold standard drugs. ...
(Date:11/19/2008)...St. Jude scientists report basic findings on criti...ing how to better treat an array of disorders , ...ire/ -- Scientists at St. Jude Children,s Researc...n of one of the body,s enzyme workhorses called ca...hievers, calpains function in many cellular proces...
(Date:11/18/2008)...LONDON, November 19 Neur...ce service provider and drug development Company,... Index: 4565), a leading,international biopharmac...s,is presenting further pivotal pre-clinical effi... drug is a potential therapy for neuropathic pain ...
(Date:11/18/2008)...American Lung Association,s 2008 Faces of Influenz...lies immunized against influenza; Mother and Gold ..., WASHINGTON, Nov. 18 While 78 ...nfluenza a severe and potentially life-threatening...is likely their families will get vaccinated this ...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Medical Marketing Veteran Signs on as Director of Strategy and New Business Development at Active Imagination 15521 1Medical Marketing Veteran Signs on as Director of Strategy and New Business Development at Active Imagination 15521 2The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping Immunogenotyping Laboratory 4282 1The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping Immunogenotyping Laboratory 4282 2The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping Immunogenotyping Laboratory 4282 3Radioactive progenies of thoron can be measured accurately thanks to the PTB 15516 1Princeton Professor David W C MacMillan Lectured WuXi PharmaTech Scientists 15512 1Princeton Professor David W C MacMillan Lectured WuXi PharmaTech Scientists 15512 2
...macokinetics Similar to IV Doses in,Phase 3 CLL Tr...wire-FirstCall/ --,Genta Incorporated announced th... show the Company,s lead anti-cancer drug,Genasen...,administered by intermittent subcutaneous (SC) in...sion. These regimens may,eventually reduce or elim...
...NESS WIRE)--Jun 6, 2007 - Savient,Pharmaceuticals,...racts exploring Phase 2 Puricase(R) (PEG-uricase) ... patients will be,presented at the European League...aking place June 13 - 16th in Barcelona, Spain.,Pu...idase currently,in Phase 3 development for patient...
Other Medicine Technology:Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 2Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 3Genta Announces Results of Phase 1 Study Using Genasense,Administered by Intermittent Subcutaneous Injection 4Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 2Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 3Savient Pharmaceuticals Announces Acceptance of Two Gout-Related,Abstracts for Poster Presentation at the European League Against,Rheumatism (EULAR) 2007 Annual Congress 4
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...
Medicine Products: